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Background: Negative energy balance (NEB), an altered metabolic state, occurs in early postpartum dairy cattle
when energy demands to support lactation exceed energy intake. During NEB the liver undergoes oxidative stress
and increased breakdown of fatty acids accompanied by changes in gene expression. It is now known that micro
RNAs (miRNA) can have a role in mediating such alterations in gene expression through repression or degradation
of target mRNAs. miRNA expression is known to be altered by metabolism and environmental factors and miRNAs
are implicated in expression modulation of metabolism related genes.
Results: miRNA expression was profiled in the liver of moderate yielding dairy cattle under severe NEB (SNEB) and
mild NEB (MNEB) using the Affymetrix Gene Chip miRNA_2.0 array with 679 probe sets for Bos-taurus miRNAs. Ten
miRNAs were found to be differentially expressed using the ‘samr’ statistical package (delta = 0.6) at a q-value FDR
of < 12%. Five miRNAs including miR-17-5p, miR-31, miR-140, miR-1281 and miR-2885 were validated using RT-qPCR,
to be up-regulated under SNEB. Liver diseases associated with these miRNAs include non-alcoholic fatty liver (NAFLD)
and hepatocellular carcinoma (HCC). miR-140 and miR-17-5p are known to show differential expression under oxidative
stress. A total of 32 down-regulated putative target genes were also identified among 418 differentially expressed
hepatic genes previously reported for the same animal model. Among these, GPR37 (G protein-coupled receptor
37), HEYL (hairy/enhancer-of-split related with YRPW motif-like), DNJA1, CD14 (Cluster of differentiation 14) and
GNS (glucosamine (N-acetyl)-6-sulfatase) are known to be associated with hepatic metabolic disorders. In
addition miR-140 and miR-2885 have binding sites on the most down-regulated of these genes, FADS2 (Fatty
acid desaturase 2) which encodes an enzyme critical in lipid biosynthesis. Furthermore, HNF3-gamma (Hepatocyte
nuclear factor 3-gamma), a hepatic transcription factor (TF) that is involved in IGF-1 expression regulation and
maintenance of glucose homeostasis is a putative target of miR-31.
Conclusions: This study shows that SNEB affects liver miRNA expression and these miRNAs have putative
targets in hepatic genes down-regulated under this condition. This study highlights the potential role of miRNAs
in transcription regulation of hepatic gene expression during SNEB in dairy cattle.Background
Over the past few decades improvements in milk pro-
duction through genetic selection have been associated
with a reduction in cow fertility and this decrease in
fertility has become a major concern for dairy producers
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reproduction in any medium, provided the orand an altered metabolic state called NEB has been
established as one of the major physiological causes of
decreased fertility in high yielding dairy cattle [3-5]. NEB
is the result of increased energy demands to support lac-
tation, coupled with lowered feed intake [4,5]. Immune
related and hepatic functions are known to be effected
by NEB [6-9] and there is an increased metabolic load
on the liver to overcome the energy deficit under NEB.
There is a dramatic increase in hepatic oxidation of fatty
acids for energy production [9,10] and in addition there
are extra demands on the liver to increase glycogenesisLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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order to understand the complex metabolic adjustments
in postpartum dairy cattle liver during NEB, a dairy cattle
model based on different milking regimes was developed.
Earlier in a microarray gene expression study 418 hepatic
genes were reported to be differentially expressed as a re-
sult of SNEB [9]. These differentially expressed genes have
roles in lipid metabolism and glycogenic processes, im-
mune response and the somatotropic axis involved in milk
production. The regulation in gene expression under
SNEB, however, is yet to be fully understood.
It is now known that a class of small RNAs called
miRNA, about 19 to 25 nucleotides in length, can regulate
such alterations at the gene expression level. miRNAs
were first discovered from the round worm C. Elegans al-
most 3 decades ago [11]. Since their discovery, hundreds
of miRNAs have been identified across the plant and
animal kingdoms. It is estimated that whereas only 1-5%
of genomic transcripts in mammals code miRNAs, up to
60% of genes are regulated by miRNAs [12-14].
The biogenesis of miRNA is a multistep process that
begins with miRNA gene transcription resulting in pri-
mary miRNA (pri-miRNA) in the nucleus, followed by
the generation of around 70nt long stem–loop precursor
miRNAs (pre-miRNAs) from pri-miRNA. Pre-miRNAs
are then translocated to the cytoplasm where they are
trimmed to remove the terminal loop and release ~22 nt
long duplex mature miRNAs containing a guiding strand
and a passenger strand. The guiding strand assembles
into cytoplasmic RNA-induced silencing complex (RISC)
with argonaute protein that guides the complex to their
complementary mRNA targets [15,16]. The miRNA target-
mRNA complementary base-pair interaction generally
occurs between the target site on the 3′UTR of the
mRNA and the 2nd to 8th nucleotides on the 5′UTR of
the miRNA called the ‘seed region’. Generally, miRNAs
repress translation through deadenylation of mRNA
leading to their subsequent degradation or translation
repression. miRNAs are reported to regulate a wide
range of biological processes including cell cycle regulation,
proliferation and differentiation as well as development,
immune response, carcinogenesis and various metabolic
processes [17-19]. The effects of metabolites and environ-
mental factors including hormones, cytokines and nutri-
ents on miRNAs is well established [20-24]. Alterations in
cattle liver miRNA expression in response to external ana-
bolic steroids was reported and miRNAs were suggested as
potential biomarker for drug abuse in cattle [24]. In
another study testosterone treatment was reported to alter
miR-22, miR-690, miR-122, let-7a, miR-30 and let-7d ex-
pression in female rat liver [25]. Increases in expression of
miR-155 and miR-132 due to oxidative stress was reported
in an ALD (alchololic liver disorder) mouse model [26].
Oxidative stress of hepatocytes was also reported to altermiR-199a-5p expression [27]. Nutritional modulation of
miRNA expression has been reported in various dietary
intervention studies of metabolic disorders like obesity,
diabetes and fatty liver [28-30]. A high fat diet was reported
to alter the adipose tissue miRNA expressional profile of
miR-19a, -92a, -92b, -101, -103, -106, -142–5p, and 296 in
cattle [31]. miRNAs can regulate metabolism and homeo-
stasis of high energy metabolites as well as insulin signal-
ling and glucose homeostasis [32-34]. miR-33a and
miR-33b located within the sterol regulatory element-
binding proteins (SREBP), key transcription regulators
of genes involved in cholesterol biosynthesis and up-
take, regulate cholesterol homeostasis jointly with their
host genes [35] and have roles in the regulation fatty
acid metabolism and insulin signaling [36]. In addition,
miR-122, a liver specific miRNA regulates hepatic fatty
acid oxidation and fatty acid and cholesterol synthesis
rate [32,37]. miRNAs are associated with the patho-
physiology of hepatic metabolic disorders like NAFLD
and NASH (non-alcoholic steatohepatitis) as well as
HCC in mouse and human studies [38-41]. The poten-
tial role miRNAs have to play in NEB in the dairy cow
remains to be elucidated.
This study set out to determine a) if hepatic miRNA
expression was altered as a result of SNEB in a model of
moderate yielding Holstein Friesian dairy cows in the
early postpartum period, and b) to integrate hepatic miRNA
and mRNA expression profiles through prediction of targets
of these miRNAs among a set of previously reported differ-
ential expressed hepatic genes under SNEB from the same
animal model. Elucidation of the expression patterns of
miRNAs and computational identification of their putative
target among genes regulated under SNEB will contribute to
the understanding of the roles of miRNAs in regulating gene
expression during SNEB in dairy cows.
Methods
Animal model
The animal model employed in this study has been de-
scribed previously [5,9]. All procedures were carried out
under license in accordance with the European Commu-
nity Directive, 86-609-EC. In brief, multiparous Holstein-
Friesian cows were blocked according to parity, body
condition score, and previous milk yield, two weeks
prior to expected calving and within block were ran-
domly allocated to two treatments; mild NEB (MNEB,
n = 12) or severe NEB (SNEB, n = 12) groups based on
different feeding and milking regimes. On day 2 after
calving, MNEB cows were fed ad libitum grass silage
with 8 kg per day of a 21% crude protein dairy concen-
tration and milked once daily; SNEB cows were fed 25
kg of silage per day silage with 4 kg of crude protein
per day and milked three times daily. Three times a
day versus once a day milking was used to advance a
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drawal with a concomitant lower need for differences
in energy intake between groups. The chemical com-
position of silage and concentrate offered as previously
described [5]. For sample collection, cows were se-
lected from each group based on extremes of energy
balance (MNEB, n = 6; SNEB, n = 6). Cows were slaugh-
tered approximately 14 days postpartum (MNEB; 13.6 ±
0.75, range 11–15; SNEB 14.3 ± 0.56, range 13–16) [9].
Liver tissues were retrieved within 30 min of slaughter
and snap frozen at -80°C. One MNEB cow was removed
retrospectively as she was deemed to be ill during the
experimental period.
RNA extraction and quality analysis
For the purpose of RNA extraction, 100 mg frozen liver
tissue was directly immersed in 1 ml Trizol (Invitrogen,
Stockholm, Sweden). A Precellys 24 homogeniser (Bertin
Technologies, Montigny-le-Bretonneux, France) was used
to homogenise the tissue (6000 rpm for 20 sec). Hom-
ogenate was left for 5 min at RT to permit the complete
dissociation of nucleoprotein complexes followed by cen-
trifugation at 12,000 g for 10 min at 4°C. Supernatant
was transferred to a 2 ml tube. 2μl of Pellet paint® NF
Co-Precipitant (EMD Millipore, Darmstadt, Germany)
and 200 μl chloroform was added and incubated at RT
for 5 min. After centrifugation for 15 min at 4°C and
14000 g the aqueous phase was transferred into a new
tube and 500 μl isopropanol was added and incubated
for 5 min on ice. Following centrifugation for 10 min
at 4°C and 14000 g the supernatant was removed and
the pellet washed with 500 μl 75% ETOH followed by
centrifugation for 10 min at 4°C and 14000 g. A 100 μl
aliquot of nuclease-free water was added to the pellet
and incubated at RT for 10 min. After vortexing for
1 min 10 μl of 3 M sodium acetate was added. Next,
250 μl ice cold ETOH was added and incubated for
1 hr at -20°C, followed by centrifugation at 4°C for
10 min and 14000 g. The supernatant was removed
and washed with 500 μl of 75% EtOH by vortexing
followed by centrifugation at 4°C for 10 min and
14000 g. The supernatant was removed and the pellet
was air-dried for 5 min at RT following which 30μl of
RNase-free water was added and left for 5 min. RNA
quality and quantity was assessed using a NanoDrop
spectrophotometer (ND-1000; Wilmington, DE, USA)
and Bioanalyzer 2100 (Agilent Technologies Ireland,
Dublin, Ireland). Mean RIN values were > 8. Total RNA
was stored at -80°C.
Gene Chip miRNAs_2.0 array hybridization
Total RNA from liver samples of 11 cows were hybridized
to the Affymetrix Gene Chip miRNA_2.0 (Affymetrix,
Santa Clara, CA, USA) arrays for miRNA expressionprofiling. This array has miRBase v15 coverage (www.
mirbase.org) with 15,644 probe sets of 131 organisms
including 679 probe sets for Bos-taurus miRNAs. Array
hybridization was carried out at ATLAS Biolabs, Berlin,
Germany. Briefly, 200 ng total RNA labelled with Flash
Tag Biotin was hybridized to the miRNA Array in a
Hybridization Oven 640 (Affymetrix) at 48°C for 18 h.
The arrays were stained with the Fluidics Station 450
using fluidics script FS450_0003 (Affymetrix), and then
scanned on a GeneChip Scanner 3000 7G (Affymetrix,
Santa Clara, CA, USA).
Statistical analysis
All statistical analyses were performed in the R statistical
computing environment (Version 2.14; http://www.r-project.
org) with the samr package from the Bioconductor project
(http://www.bioconductor.org). Data quality was assessed
with the ArrayQualitymetrix package from Bioconductor
[42,43]. One cel file from each group was discarded due to
issues with hybridisation quality. The expresso method of
the Affy package [44] was used to pre-processes the
data with quantile normalization and median polish
summarization. While the chip contains probes com-
plementary to miRNA from other species only the
expression intensities of 679 cattle miRNAs were used
for further analysis. The Significance Analysis of Micro-
array (SAM) two-class unpaired method implemented in
the samr Bioconductor package was used to identify
differentially expressed miRNAs [45]. The samr par-
ameter delta 0.6 was selected that classified miRNAs
as differentially expressed at a fold-change > 1.25 and a
q-value < 12%.
RT-qPCR validation of differentially expressed miRNAs
Seven candidate miRNAs differentially expressed on the
microarray; including miR-17-5p, miR-31, miR-140, miR-
1281, miR-2885, miR-296, and miR-671 were selected for
RT-qPCR validation. miRNA expression was carried out
with TaqMan miRNA RT-qPCR assays according to the
manufacturer’s instructions (Applied Biosystems, Dublin,
Ireland). miRNA-specific reverse transcription was per-
formed on 10 ng of purified total RNA using the TaqMan
MicroRNA Reverse Transcription kit according to manu-
facturer’s instructions. RT-qPCR reactions were performed
using 1 μl of cDNA (10 ng/μl) in 9 μl of Taqman universal
master mix containing TaqMan PCR primers and probes
on a BioRad CFX96 real time PCR system (Bio-Rad,
Hemel Hempstead, UK) using the following cycling pa-
rameters; 95°C for 10 min followed by 40 cycles at 95°C
for 15 s and 60°C for 1 min. Four biological replicates
from each of the MNEB and SNEB treatment groups were
used for RT-qPCR validation. Three reference miRNAs in-
cluding miR-122, let-7b and RNU6B were tested with the
software program geNorm version 3.5 [46] for calculating
Table 1 Differentially expressed post-partum dairy cattle
miRNAs under SNEB
miRNA miRBase accession q-value (%) Fold change
bta-miR-31 MI0004762 0.00 1.79
bta-miR-1281 MI0010466 11.97 1.71
bta-miR-2483 MI0011545 11.97 1.56
bta-miR-2885 MI0013058 0.00 1.55
bta-miR-296 MI0009786 11.97 1.52
bta-miR-2316 MI0011336 11.97 1.40
bta-miR-140 MI0005010 11.97 1.33
bta-miR-17-5p MIMAT0003815 11.97 1.30
bta-miR-671 MI0009887 11.97 1.29
bta-miR-2455 MI0011512 11.97 1.28
Differential expression analysis was done for microarray expression intensities
of 679 bovine miRNAs with SAM (significance analysis of microarrays) method
at delta parameter of 0.6 and q FDR < 12%.
Table 2 Differentially expressed postpartum dairy cattle
hepatic miRNAs under SNEB
miRNA Fold change p value
bta-miR-31 4.11 0.033
bta-miR-1281 3.10 0.042
bta-miR-2885 2.91 0.006
bta-miR-17-5p 4.62 0.008
bta-miR-140 3.90 0.030
bta-miR-296 0.85 0.490
bta-miR-671 0.92 0.930
Differential expression analysis was carried out with PROC t-test (SAS) after
normalization of Ct-values to reference gene RNU6B.
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was found to be the most stable internal reference miRNA
across treatments with an M value of 0.7. It was more
stable on its own than when used in combination with the
two other reference miRNA. The software package BioRad
CFX manager was used for correction of the Ct values
and normalization to RNU6B using the 2-ΔΔCt method
[47]. Corrected Ct values were used to calculate differen-
tial expression using the PROC t-test (SAS) [48].
Prediction of differentially expressed miRNAs targets
among differentially expressed hepatic genes under SNEB
A target prediction algorithm for custom data, from the
TargetScan database website [13] implemented in Perl
(targetscan_61_context_scores.pl), was used to identify
target sites of differentially expressed miRNAs in the
3′UTRs of 418 differentially expressed genes reported
previously for the same liver tissue [9]. Using this algo-
rithm, conserved 8mer and 7mer sites matching the
seed region of each miRNA in the 3′UTRs of differen-
tially expressed hepatic genes were identified [49]. Non-
conserved sites and sites with mismatches in the seed
region that were compensated by conserved 3′ pairing
were also included [13]. Predictions were ranked based
on the context + scores of the sites that represent the
predicted efficacy of targeting [50]. GO (Gene Ontol-
ogy) biological processes associations of 3 conserved
miRNAs (miR-31, miR 17-5p and miR-140) were re-
trieved using FAME (functional assignment of miRNAs
via enrichment) software [51]. No data was available
for miR-1281 and miR-2885 in the FAME database.
The FAME algorithm makes direct inference of a
specific miRNA function using enriched subsets of the
target genes sharing a common biological process or
pathway. The GO biological processes associated with
down-regulated putative targets were retrieved from
the UniProt Gene Ontology Annotation (GOA) data-
base (http://www.ebi.ac.uk/GOA).
Results
Ten out of 679 mature bovine miRNAs represented on
the miRNA Gene Chip miRNA_2.0 array were found to
be up-regulated in SNEB cows. Table 1 lists the miRNAs
that showed differential expression between MNEB and
SNEB groups. RT-qPCR results confirmed the differen-
tial expression of 5 out of the 7 miRNAs tested. The
expression of miR17-5p, -1281, -140, 2885 and -31 were
consistent between microarray and RT-qPCR whereas
miR-296 and miR-671 were not significant. Table 2 lists
the differentially expressed miRNAs validated by RT-
qPCR. Putative targets of these five miRNAs were identi-
fied in the set of 418 (230 down- and 188 up-regulated)
hepatic genes reported previously in the same animal
model. Among the 418, 67 (35 up-regulated and 32down-regulated) genes were found to have target sites in
the 3′UTRs of the up-regulated miRNAs (Table 3).
All of the five differentially expressed miRNAs vali-
dated by RT-qPCR in this study were up-regulated how-
ever there was no significant enrichment among the
down-regulated putative targets genes using the Fisher
test for enrichment analysis. Overall miR-140 was found
to have the most putative targets among differentially
expressed genes under SNEB while miR-17-5p had the
second highest number of targets. As the consensus is
that up-regulated miRNAs result for the most part in
down-regulation of their target genes, we further se-
lected only down-regulated genes as putative affected
targets for subsequent analysis to investigate the role
of differentially expressed miRNAs under SNEB. As
miRNAs are thought not to switch off their targets
completely but rather fine-tune their expression, all
down-regulated genes were included irrespective of
fold-change. Figure 1 presents the subset of the puta-
tive down-regulated targets for these up-regulated
miRNAs. miR-140 had the highest number of putative
down-regulated target genes followed by miR-17-5p.
Table 3 Putative target genes of up-regulated hepatic miRNAs differentially expressed under SNEB
Down-regulated putative targets Up-regulated putative targets
Symbol Gene name Symbol Gene name
ALDH1A1 aldehyde dehydrogenase 1 family, member A1 AADAT aminoadipate aminotransferase
BTG1 B-cell translocation gene 1, anti-proliferative ACP2 Acid phosphatase 2, lysosomal
CCL19 chemokine (C-C motif) ligand 19 ADTRP Androgen-Dependent TFPI-Regulating Protein
CD14 CD14 molecule ARG1 Arginase, liver
CIB1 Calcium and integrin binding 1 (calmyrin) BIN1 Bridging integrator 1
DNAJA1 DnaJ (Hsp40) homolog, subfamily A, member 1 BNIP3L BCL2/adenovirus E1B 19 kDa interacting protein 3-like
DSG1 desmoglein 1 CMPK1 cytidine monophosphate (UMP-CMP) kinase 1, cytosolic
EPB41L5 Erythrocyte membrane protein band 4.1 like 5 CNN1 Calponin 1, Basic, Smooth Muscle
ERRFI1 ERBB receptor feedback inhibitor 1 CPQ carboxypeptidase Q
FADS2 Fatty acid desaturase 2 CPT1B carnitine palmitoyltransferase 1B (muscle)
FOXA3 Forkhead box A3 DENND2D DENN/MADD domain containing 2D
FXR1 Fragile X mental retardation, autosomal homolog 1 DPYD dihydropyrimidine dehydrogenase
GKAP1 G kinase anchoring protein 1 HDC histidine decarboxylase
GNS glucosamine (N-acetyl)-6-sulfatase HMGN4 High mobility group nucleosomal binding domain 4
GPBP1 GC-rich promoter binding protein 1 HSF2BP Heat shock transcription factor 2 binding protein
GPR37 G protein-coupled receptor 37
(endothelin receptor type B-like)
IL1A Interleukin 1, alpha
HEYL hairy/enhancer-of-split related with YRPW motif-like LPCAT3 Lysophosphatidylcholine acyltransferase 3
IP6K2 inositol hexakisphosphate kinase 2 MBL2 Mannose-binding lectin (protein C) 2, soluble
(opsonic defect)
KIAA1 191 KIAA1 191 MINA MYC induced nuclear antigen
MIEN1 Migration and invasion enhancer 1Bottom of Form NHEJ1 Nonhomologous end-joining factor 1
MIS 12 MIND kinetochore complex component, homolog (S. pombe) OAT ornithine aminotransferase (gyrate atrophy)
NR2F1 nuclear receptor subfamily 2, group F, member 1 PDRG1 p53 and DNA-damage regulated 1
PRSS35 protease, serine, 35 POLR3GL polymerase (RNA) III polypeptide G (32kD)-like
PTPRR protein tyrosine phosphatase, receptor type, R RCAN3 RCAN family member 3
RNF 128 ring finger protein 128 REEP5 Receptor accessory protein 5
Putative binding sites were identified in the 3′UTR of differentially expressed hepatic genes under SNEB with the Targetscan algorithm.
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while miR-1281 had all but one of its putative target genes
down-regulated under SNEB. miR-2885 has FADS2 as its
only putative down-regulated target under SNEB and
FADS2 is also a putative target of miR-140. DSG1 (desmo-
glein1) and FXR1 (fragile X mental retardation, autosomal
homolog 1) are both shared targets of miR-17-5p and
miR-31 while GNS (glucosamine-N-acetyl-6-sulfatase) is a
shared target of mir-140 and miR-31 (Figure 2). Table 4
lists the bio-types of putative targets down-regulated
under SNEB. The GO biological processes associated with
down-regulated putative targets are given in Additional
file 1: Table S1. The overall GO biological functions asso-
ciated with three conserved miRNAs that are relevant in
terms of SNEB are given in Additional file 1: Table S2.
miR-31 is associated with the GO biological processes of
cell growth, amino acid transport and response to stress.miR-17-5p is associated with GO biological processes
include regulation of cell cycle and protein metabolism.
miR-140 is associated with GO biological processes of cell
proliferation, polysaccharide metabolism and signal trans-
duction, while both miR-31 and miR-140 are associated
with response to nutritional level.
Discussion
Dairy cows enter a state of NEB postpartum when the
energy supply is prioritised towards the mammary
tissues for milk production while the energy intake is
reduced. The principal physiological response to the
energy deficit is mobilization of non-esterified fatty acids
(NEFA) from adipose tissue. NEFAs are broken down in
the liver to release energy and any incomplete break-
down results in production of BHB (β-hydroxybutyrate)
or TAGs (triacylglycerides). Accumulation of TAGs, BHB
miR-140 FC mir17-5p FC bta-miR-31 FC mir2885 FC miR-1281 FC
FADS2 -19.60 DSG1 -2.10 DSG1 -2.10 FADS2 -19.60 HEYL -2.27
CCL19 -1.50 GPR37 -1.84 FOXA3 -2.04 RNF4 1.19 SLC1A4 -2.20
BTG1 -1.44 SYBU -1.72 PTPRR -1.48 LPCAT3 1.25 IP6K2 -1.43
TSC22D1 -1.41 PRSS35 -1.50 MIS12 -1.42 BIN1 1.47 NR2F1 -1.19
KIAA1191 -1.32 TTR -1.32 CD14 -1.39 TUFT1 2.05 POLR3GL 1.15
DNAJA1 -1.31 FXR1 -1.26 FXR1 -1.26 SCARB1 2.62
MIEN1 -1.28 RNF128 -1.24 NHEJ1 1.27 SLC25A34 3.29
EPB41L5 -1.25 TPMT -1.24 ARG1 1.32
ERRFI1 -1.25 GKAP1 -1.21 SEC61A2 1.41
CIB1 -1.15 ALDH1A1 -1.12 OAT 1.59
GNS -1.12 GNS -1.12 HSF2BP 1.80
STAMBP -1.09 CMPK1 1.15 SLC25A48 1.93
TMX1 -1.09 HMGN4 1.17
GPBP1 -1.08 RNF4 1.20
DPYD 1.12 BNIP3L 1.20
MINA 1.13 SLC27A4 1.25
SNAPIN 1.15 CNN1 1.29
POLR3GL 1.15 ARG1 1.32
HMGN4 1.17 AADAT 1.33
SUMO3 1.18 CPQ 1.86
THG1L 1.21 IL1A 2.03
ADTRP 1.22
DENND2D 1.26
REEP5 1.28
MBL2 1.35
PDRG1 1.38
ACP2 1.38
HDC 1.45
RCAN3 1.52
TUFT1 2.04
SCARB1 2.61
SLC25A34 3.29
CPT1B 5.52
Colour index fold change
Figure 1 Predicted miRNA gene targets with fold-change under SNEB.
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liver that can lead to fatty liver or lipidosis. In addition
components of the somatotrophic axis like IGF (insulin
like growth factor) and GH (growth hormones) that have
roles in the control of milk production are also affected
by SNEB [8-10]. Reduced IGF1 expression is also nega-
tively correlated with fertility in dairy cows [52]. Previ-
ous nutritional supplementation of animals in NEB with
lipogenic and glycogenic nutrients partly succeeded in
compensating for energy partitioning between mammarytissues and the rest of the body [4,53]. However, the
regulation of such alterations is yet to be explored. In
this study, five miRNAs were altered in response to
SNEB. Two of these miRNAs have been reported to be
altered under oxidative stress in humans [41,54] and
miR-17-5p has been associated with oxidative stress in
HCC [41]. In addition alterations in miR-140 expression
under chemical and oxidative stress has also been re-
ported [54]. Three of the miRNAs, miR- 17, miR-31 and
miR-140, found to be up-regulated under SNEB have
Figure 2 Hexagons represent the up-regulated miRNAs with edges leading to nodes representing their putative targets down-regulated
under SNEB. Nodes with two edges represent putative targets shared by two up-regulated miRNAs.
Table 4 Intracellular location and bio-types of down-regulated putative gene targets of up-regulated miRNAs
Symbol Entrez gene name Location Type
KIAA1191 KIAA1191 Cytoplasm Other
MIEN 1 Migration and invasion enhancer 1 Cytoplasm Other
MIS 12 MIS 12, MIND kinetochore complex component, homolog (S. pombe) Nucleus Other
NR2F1 Nuclear receptor subfamily 2, group F, member 1 Nucleus Ligand-dependent nuclear receptor
PRSS35 Protease, serine, 35 Extracellular space peptidase
PTPRR Protein tyrosine phosphatase, receptor type, R Plasma membrane phosphatase
RNF 128 Ring finger protein 128, E3 ubiquitin protein ligase Cytoplasm Enzyme
SLC1A4 Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 Plasma membrane Transporter
STAMBP STAM binding protein Nucleus Enzyme
SYBU Syntabulin (syntaxin-interacting) Unknown Other
TMX1 Thioredoxin-related transmembrane protein 1 Cytoplasm Enzyme
TPMT Thiopurine S-methyltransferase Cytoplasm Enzyme
TTR Transthyretin1 Cytoplasm Transporter
ALDH1A1 Aldehyde dehydrogenase 1 family, member A1 Cytoplasm Enzyme
BTG1 B-cell Translocation gene 1, anti-proliferative Nucleus Transcription Regulator
CCL19 chemokine (C-C motif) ligand 19 Extracellular space Cytokine
CD14 CD14 molecule Plasma Membrane Transmembrane receptor
CIB1 Calcium and integrin binding 1 (calmyrin) Nucleus Other
DNAJA1 DnaJ (Hsp40) homolog, subfamily A, member 1 Nucleus Other
DSG1 Desmoglein 1 Plasma membrane Membrane protein
EPB4 1 L5 Erythrocyte membrane protein band 4.1 like 5 Plasma membrane Membrane protein
ERRFI1 ERBB receptor feedback inhibitor 1 Cytoplasm Other
FADS2 Fatty acid desaturase 2 Plasma membrane Enzyme
FOXA3 Forkhead box A3 Nucleus Transcription regulator
FXR1 Fragile X mental retardation, autosomal homolog 1 Cytoplasm Other
GKAP1 G kinase anchoring protein 1 Cytoplasm Other
GNS Glucosamine (N-acetyl)-6-sulfatase Cytoplasm Enzyme
GPBP1 GC-rich promoter binding protein 1 Nucleus Transcription regulator
GPR37 G protein-coupled receptor 37 (endothelin receptor type B-like) Plasma membrane G-protein coupled receptor
HEYL Hairy/enhancer-of-split related with YRPW motif-like Nucleus Transcription regulator
IP6K2 Inositol hexakisphosphate kinase 2 Cytoplasm Kinase
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and miR-140 has been associated with NAFLD [40,57]. A
regulatory role for miR-17-5p has been reported in HCC
[55,56] while miR-31 has also been associated with both
NAFLD and HCC [58-60].
A number of the putative down-regulated targets of
the differentially expressed miRNAs in this study are
known to have roles in hepatic disorders. These include
the miR-17-5p target GPR37 (G protein-coupled recep-
tor 37) a member of the G-protein coupled receptor-1
family associated with NAFLD [61]. The miR-1281 tar-
get HEYL (hairy/enhancer-of-split related with YRPW
motif-like) is associated with HCC [62,63]. The miR-140
target DNJA1 that has a role in lipid intake is associated
with the oxidative stress response of high fat induced
NAFLD [28,30]. The miR-31 target, CD14 (Cluster of
differentiation 14) involved in transmission and release
of polysaccharides, is also implicated in ALD, hepatic
cholestasis and hepatic fibrosis [64,65]. The miR-17-5p
target GNS (glucosamine (N-acetyl)-6-sulfatase) that
metabolises glucosamine sulphate has been implicated in
hepatocellular dysplasia, cirrhosis of the liver and hep-
atic fibrosis [66]. Moreover, the miR-17-5p target TTR, a
carrier protein for transport of lipid soluble vitamins
from the liver to the circulation is also reduced under
SNEB. Reduced TTR expression has been reported in a
study of periparturient period Holstein and Jersey dairy
cows in NEB [67]. In addition we were able to postulate
a role for miR-31 in SNEB through its putative target
hepatic transcription factor FOXA3 also known as
HNF3-gamma. Bovine IGF-I has binding sites for HNF3-
gamma in its promoter region [68]. While another re-
cent human study reported target sites of miR-31 on the
3′UTR of IGF-1 [69]. HNF-gamma is also known to be
involved in glucose homeostasis in hepatocytes through
regulation of GLUT2 (glucose transporter 2) [70,71].
However, the most interesting putative target of all was
the gene encoding the lipogenesis enzyme FADS2 which
is critical for long-chain polyunsaturated fatty acids
biosynthesis [72]. In this study we found binding sites
for two up-regulated miRNAs miR-140 and miR-2885
in the 3′UTR of FADS2, whereas miR-140 has been
previously implicated in the regulation of FADS2
homolog FADS1 [73].
Conclusion
This study suggests a role for hepatic miRNAs in lipid
and energy metabolism through the identification of a
subset of their putative targets associated with important
metabolic processes. Moreover hepatic miRNAs associ-
ated with genes involved in the somatotropic axis can be
a possible link between reduced reproductive perform-
ance and SNEB in the early postpartum dairy cow. Fur-
ther direct functional studies of selected miRNA-mRNAputative pairs in the liver of such models will help to im-
prove our understanding of the molecular mechanisms
and pathways involved in SNEB in postpartum dairy
cattle.
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